Skip to content

Transcutaneous spinal cord stimulation (tSCS) for the treatment of spasticity and gait disorders in multiple sclerosis

Transcutaneous spinal cord stimulation (tSCS) for the treatment of spasticity and gait disorders in multiple sclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023357
Enrollment
10
Registered
2021-04-19
Start date
2021-06-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G35 G35.2 G35.3

Interventions

Group 1: Measurement No.1: Sham Measurement No.2: 50 Hz Group 2: Measurement No.1: 50 Hz Measurement No.2: Sham

Sponsors

Charité Campus Charité Mitte
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: confirmed diagnosis of multiple sclerosis with a moderate to severe spasticity (Modified Ashworth Scale scores of 2-4)

Exclusion criteria

Exclusion criteria: 1) Active lumbosacral nerve root compression 2) status after operation of the vertebral bodies in the stimulation area, as well as metal implants in the stimulation area (distance at least 5 cm from the edge of the adhesive electrode) 3) pacemaker implant 4) MS flare-up event in the past 6 months 5) Current pregnancy

Design outcomes

Primary

MeasureTime frame
Reduction of spasticity with transcutaneous spinal cord stimulation (clinical assesment with Modified Ashworth Scale)

Secondary

MeasureTime frame
a) Extension of the walking distance in the 2-minute gait test. c) Improvement of the walking speed in the 10-meter walking test and timed up-and-go test. d) Correlation of the spasticity assessment in the clinical assessment (Modified Ashworth Scale) with electrophysiological parameters (tSCS reflexes) d) Improvement of kinematic data of the lower extremity (e.g. range of motion of the ankle) e) Investigation of side-specific and joint-specific spasticity changes f) Examination of tolerance (pain questionnaire)

Countries

Germany

Contacts

Public ContactNikolaus Wenger

Charité – Universitätsmedizin Berlin

nikolaus.wenger@charite.de030450-660099

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026